-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $120

Benzinga·07/07/2026 15:39:29
Listen to the news
RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $122 to $120.